Universal in vitro antifungal resistance of genetic clades of the Fusarium solani species complex
- PMID: 17220423
- PMCID: PMC1855466
- DOI: 10.1128/AAC.01618-06
Universal in vitro antifungal resistance of genetic clades of the Fusarium solani species complex
Abstract
Eleven antifungal drugs were tested against representative isolates of the four phylogenetic clades of the Fusarium solani species complex obtained in a multilocus sequence analysis. They all showed very poor activity, with no differences among the clades. Amphotericin B was the most active drug.
Figures
Similar articles
-
Rifampin Enhances the Activity of Amphotericin B against Fusarium solani Species Complex and Aspergillus flavus Species Complex Isolates from Keratitis Patients.Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02069-16. doi: 10.1128/AAC.02069-16. Print 2017 Apr. Antimicrob Agents Chemother. 2017. PMID: 28115342 Free PMC article.
-
In vitro resistance of clinical Fusarium species to amphotericin B and voriconazole using the EUCAST antifungal susceptibility method.Diagn Microbiol Infect Dis. 2016 Aug;85(4):438-43. doi: 10.1016/j.diagmicrobio.2016.05.006. Epub 2016 May 12. Diagn Microbiol Infect Dis. 2016. PMID: 27312690
-
Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods.J Antimicrob Chemother. 2008 Apr;61(4):805-9. doi: 10.1093/jac/dkn022. Epub 2008 Feb 8. J Antimicrob Chemother. 2008. PMID: 18263569
-
[Mechanisms of resistance to antifungal agents].Nihon Rinsho. 2007 Feb 28;65 Suppl 2 Pt. 1:466-70. Nihon Rinsho. 2007. PMID: 17455664 Review. Japanese. No abstract available.
-
Fusarium: Molecular Diversity and Intrinsic Drug Resistance.PLoS Pathog. 2016 Apr 7;12(4):e1005464. doi: 10.1371/journal.ppat.1005464. eCollection 2016 Apr. PLoS Pathog. 2016. PMID: 27054821 Free PMC article. Review. No abstract available.
Cited by
-
Comparative Evaluation of Etest, EUCAST, and CLSI Methods for Amphotericin B, Voriconazole, and Posaconazole against Clinically Relevant Fusarium Species.Antimicrob Agents Chemother. 2016 Dec 27;61(1):e01671-16. doi: 10.1128/AAC.01671-16. Print 2017 Jan. Antimicrob Agents Chemother. 2016. PMID: 27795379 Free PMC article.
-
Novel multilocus sequence typing scheme reveals high genetic diversity of human pathogenic members of the Fusarium incarnatum-F. equiseti and F. chlamydosporum species complexes within the United States.J Clin Microbiol. 2009 Dec;47(12):3851-61. doi: 10.1128/JCM.01616-09. Epub 2009 Oct 14. J Clin Microbiol. 2009. PMID: 19828752 Free PMC article.
-
Fusarium Infection in a Kidney Transplant Recipient Successfully Treated with Voriconazole.Case Rep Infect Dis. 2018 Aug 7;2018:3128081. doi: 10.1155/2018/3128081. eCollection 2018. Case Rep Infect Dis. 2018. PMID: 30159184 Free PMC article.
-
European Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in Europe.Eur J Clin Microbiol Infect Dis. 2014 Sep;33(9):1623-30. doi: 10.1007/s10096-014-2111-1. Epub 2014 May 3. Eur J Clin Microbiol Infect Dis. 2014. PMID: 24791951
-
Transcriptional response of Fusarium oxysporum and Neocosmospora solani challenged with amphotericin B or posaconazole.Microbiology (Reading). 2020 Oct;166(10):936-946. doi: 10.1099/mic.0.000927. Microbiology (Reading). 2020. PMID: 32644917 Free PMC article.
References
-
- Bigley, V. H., R. F. Duarte, R. D. Gosling, C. C. Kibbler, S. Seaton, and M. Potter. 2004. Fusarium dimerum infection in a stem cell transplant recipient treated successfully with voriconazole. Bone Marrow Transplant. 34:815-817. - PubMed
-
- Consigny, S., N. Dhedin, A. Datry, S. Choquet, V. Leblond, and O. Chosidow. 2003. Successful voriconazole treatment of disseminated Fusarium infection in an immunocompromised patient. Clin. Infect. Dis. 37:311-313. - PubMed
-
- Cruse, M., R. Telerant, T. Gallagher, T. Lee, and J. W. Taylor. 2002. Cryptic species in Stachybotrys chartarum. Mycologia 94:814-822. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources